As of May 26
| -0.10 / -1.65%|
The 2 analysts offering 12-month price forecasts for MediciNova Inc have a median target of 8.88, with a high estimate of 11.00 and a low estimate of 6.76. The median estimate represents a +49.28% increase from the last price of 5.95.
The current consensus among 2 polled investment analysts is to Buy stock in MediciNova Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.